Gladstone maintains an active and diverse intellectual property (IP) portfolio around technologies, novel approaches to treating disease, and specific therapies.
Several options for licensing Gladstone IP are available to both new start-ups, established companies, and research institutions.
Contact the Corporate Liaison and Ventures Team for more information on licensing opportunities.